You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 2, February 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 11TH ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, FORT LAUDERDALE, FLA
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Interleukin 1 and Its Relationship to Endotoxin Tolerance

Pablo León, MD; H. Paul Redmond, FRCSI; Jian Shou, MD; John M. Daly, MD

Arch Surg. 1992;127(2):146-151.


Abstract

• Endotoxin (lipopolysaccharide [LPS])—induced cytokine release has been implicated in the pathogenesis of sepsis. Sublethal doses of LPS induce tolerance to a septic insult. This study evaluated pretreatment with interleukin 1 (IL-1) against an LPS challenge and examined its relationship to endotoxin tolerance. C3H/HeN mice (N=100) were injected intraperitoneally with phosphate-buffered saline (control group), IL-1 (200 µg/kg), or LPS (1 mg/kg) for 3 days. On day 5, peritoneal macrophages were harvested and assayed for antimicrobial activity (superoxide anion production and Candida albicans phagocytosis). Serum cytokine levels and survival after an LPS challenge on day 5 were also assessed. Pretreatment with IL-1 or LPS significantly increased superoxide anion production, C albicans phagocytosis, and survival compared with pretreatment with phosphate-buffered solution. Interleukin 6 levels significantly decreased in the IL-1 and LPS groups. Peak levels of tumor necrosis factor significantly decreased only in the LPS group. Thus, pretreatment with IL-1 or low doses of LPS may exert protective effects by decreasing levels of interleukin 6 while increasing antimicrobial activity. Mice pretreated with IL-1 were protected from endotoxin despite elevated peak levels of tumor necrosis factor, suggesting a different mechanism for endotoxin tolerance than for tolerance to tumor necrosis factor.

(Arch Surg. 1992;127:146-151)



Author Affiliations

From the Department of Surgery and the Harrison Department of Surgical Research, University of Pennsylvania, Philadelphia.


Footnotes

Accepted for publication November 29, 1991.

Presented at the 11th Annual Meeting of the Surgical Infection Society, Fort Lauderdale, Fla, April 15, 1991.

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Toxin-induced resistance in Bacillus anthracis lethal toxin-treated macrophages
Salles et al.
Proc. Natl. Acad. Sci. USA 2003;100:12426-12431.
ABSTRACT | FULL TEXT  

Inhibition of Lipopolysaccharide-Induced Signal Transduction in Endotoxin-Tolerized Mouse Macrophages: Dysregulation of Cytokine, Chemokine, and Toll-Like Receptor 2 and 4 Gene Expression
Medvedev et al.
J. Immunol. 2000;164:5564-5574.
ABSTRACT | FULL TEXT  

Early-Onset Inflammatory Responses In Vivo to Adenoviral Vectors in the Presence or Absence of Lipopolysaccharide-Induced Inflammation
Thorne et al.
Am. J. Respir. Cell Mol. Bio. 1999;20:1155-1164.
ABSTRACT | FULL TEXT  

Cytokine Activation Through Sublethal Hemorrhage Is Protective Against Early Lethal Endotoxic Challenge
Zervos et al.
Arch Surg 1997;132:1216-1221.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.